Raptiva and Rash papular - a phase IV clinical study of FDA data

Summary:

Rash papular is reported as a side effect among people who take Raptiva (efalizumab), especially for people who are male, 50-59 old, have been taking the drug for 1 - 6 months also take Methotrexate, and have Acute kidney failure.

The phase IV clinical study analyzes which people have Rash papular when taking Raptiva. It is created by eHealthMe based on reports of 3,760 people who have side effects when taking Raptiva from the FDA, and is updated regularly.

What is Raptiva?

Raptiva has active ingredients of efalizumab. It is often used in psoriasis. eHealthMe is studying from 3,769 Raptiva users. Check the latest studies of Raptiva.

What is Rash papular?

Rash papular (redness with papule) is found to be associated with 1,129 drugs and 1,329 conditions by eHealthMe. Check the latest studies of Rash papular.

On Jul, 20, 2026

3,760 people reported to have side effects when taking Raptiva.
Among them, 13 people (0.35%) have Rash papular.

Among these 13 people:

How long have people been on Raptiva when they have Rash papular? *

What is the gender of people who have Rash papular when taking Raptiva? *

female: 15.38 %
male: 84.62 %

What is the age of people who have Rash papular when taking Raptiva? *

What are other drugs people take besides Raptiva? *

What are other side effects people have besides Rash papular? *

Transient Ischaemic Attack (a transient episode of neurologic dysfunction caused by ischemia (loss of blood flow)): 4 people, 30.77%
Castleman's Disease (a disease of lymph nodes and related tissues): 4 people, 30.77%
Skin Nodule (slightly elevated lesions on or in the skin): 3 people, 23.08%
Protein S Deficiency: 3 people, 23.08%
Headache (pain in head): 3 people, 23.08%
Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect): 3 people, 23.08%
Vision Blurred: 3 people, 23.08%
Hypoaesthesia (reduced sense of touch or sensation): 3 people, 23.08%
Difficulty In Walking: 3 people, 23.08%
Abnormal Behavior: 2 people, 15.38%

What are the existing conditions these people have? *

Oedema (fluid collection in tissue): 1 person, 7.69%
Insomnia (sleeplessness): 1 person, 7.69%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 7.69%
Dyslipidaemia (abnormal amount of lipids): 1 person, 7.69%
Constipation: 1 person, 7.69%
Blockage Of Leg Arteries: 1 person, 7.69%
Acute Kidney Failure: 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Raptiva and have Rash papular?

- Check whether Rash papular is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Raptiva:

Raptiva (3,769 reports)

Rash papular treatments and more:

Rash papular (25,753 reports)

Browse all side effects of Raptiva:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Rash papular:

Rash papular (1,129 drugs)

Browse all the conditions that are associated with Rash papular:

Rash papular (1,329 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on efalizumab (the active ingredients of Raptiva) and Raptiva (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.